Serum markers lactate dehydrogenase and S100B predict independently disease outcome in melanoma patients with distant metastasis (Q36117266)

12 August 2017

Serum markers lactate dehydrogenase and S100B predict independently disease outcome in melanoma patients with distant metastasis (English)

1 reference

12 August 2017

J Bauer

7

0 references

Ulrike Leiter

object named as

U Leiter

5

0 references

author name string

B Weide

1

1 reference

12 August 2017

M Elsässer

2

1 reference

12 August 2017

P Büttner

3

1 reference

12 August 2017

A Pflugfelder

4

1 reference

12 August 2017

T K Eigentler

6

1 reference

12 August 2017

M Witte

8

1 reference

12 August 2017

F Meier

9

1 reference

12 August 2017

C Garbe

10

1 reference

12 August 2017

language of work or name

English

0 references

publication date

10 July 2012

1 reference

British Journal of Cancer

12 August 2017

1 reference

12 August 2017

107

1 reference

12 August 2017

3

1 reference

12 August 2017

422-428

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.2012.306

12 August 2017

0 references

cites work

Does metastasectomy improve survival in patients with Stage IV melanoma? A cancer registry analysis of outcomes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405231

Final version of 2009 AJCC melanoma staging and classification

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405231

Prognostic significance of serum S100B protein in high-risk surgically resected melanoma patients participating in Intergroup Trial ECOG 1694.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405231

A single-institution validation of the AJCC staging system for stage IV melanoma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405231

Evidence and interdisciplinary consensus-based German guidelines: surgical treatment and radiotherapy of melanoma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405231

Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405231

Complete metastasectomy in patients with stage IV metastatic melanoma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405231

NDR kinases regulate essential cell processes from yeast to humans

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405231

Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405231

S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405231

Gender and other survival predictors in patients with metastatic melanoma on Southwest Oncology Group trials

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405231

Prognostic factors in metastatic melanoma: a pooled analysis of Eastern Cooperative Oncology Group trials

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405231

Lung metastases from melanoma: when is surgical treatment warranted?

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405231

Prognostic factors for survival of patients treated systemically for disseminated melanoma.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405231

Surgical resection for melanoma metastatic to the gastrointestinal tract

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405231

Predicting survival outcome of localized melanoma: an electronic prediction tool based on the AJCC Melanoma Database

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405231

Elevated serum levels of the glial marker protein S100B are not specific for schizophrenia or mood disorders.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405231

Long-term survival analysis in metastatic melanoma: serum S100B is an independent prognostic marker and superior to LDH.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405231

Active secretion of S100B from astrocytes during metabolic stress.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405231

Tyrosinase messenger RNA in peripheral blood is related to poor survival in patients with metastatic melanoma following interleukin-2-based immunotherapy.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405231

Normal values of serum S-100B predict prolonged survival for stage IV melanoma patients

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405231

Serum S100beta protein as a marker of disease activity in patients with malignant melanoma.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405231

Does complete resection of melanoma metastatic to solid intra-abdominal organs improve survival?

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405231

S100-Beta, melanoma-inhibiting activity, and lactate dehydrogenase discriminate progressive from nonprogressive American Joint Committee on Cancer stage IV melanoma

23 September 2018

1 reference

12 December 2020

Surgical therapy for distant metastases of malignant melanoma

1 reference

12 December 2020

Contemporary surgical treatment of advanced-stage melanoma

1 reference

12 December 2020

1 reference

12 December 2020

Regression analyses of prognostic factors in metastatic malignant melanoma

1 reference

12 December 2020

Prognostic factors in patients with metastatic malignant melanoma. A multivariate analysis

1 reference

12 December 2020

S-100 protein-negative malignant melanoma: fact or fiction? A light-microscopic and immunohistochemical study

1 reference

12 December 2020

Prognostic significance of serum S100B detection compared with routine blood parameters in advanced metastatic melanoma patients

1 reference

12 December 2020

Improvement of overall survival of patients with cutaneous melanoma in Germany, 1976-2001: which factors contributed?

1 reference

12 December 2020

Stage-IV melanoma and pulmonary metastases: factors predictive of survival

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.2012.306

1 reference

Dimensions Publication ID

12 August 2017

0 references

1 reference

12 August 2017

1 reference